Visium Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Visium Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-484,619	Closed	-$55.5M	–	571
2016 Q1	$55.5M	Buy	484,619 +62,016	+15%	+$7.28M	0.94%	16
2015 Q4	$60.2M	Sell	422,603 -93,791	-18%	-$10.8M	0.9%	19
2015 Q3	$46.4M	Buy	516,394 +16,135	+3%	+$1.7M	0.63%	24
2015 Q2	$57.6M	Buy	500,259 +62,251	+14%	+$6.54M	0.82%	20
2015 Q1	$41.8M	Buy	438,008 +33,140	+8%	+$2.48M	0.62%	27
2014 Q4	$27.2M	Sell	404,868 -2,493	-0.6%	-$154K	0.38%	46
2014 Q3	$22M	Buy	407,361 +18,752	+5%	+$923K	0.32%	59
2014 Q2	$17.3M	Buy	388,609 +343,935	+770%	+$14M	0.27%	63
2014 Q1	$1.55M	Buy	44,674 +4,671	+12%	+$149K	0.03%	423
2013 Q4	$1.15M	Hold	40,003	–	–	0.02%	429
2013 Q3	$1.17M	Hold	40,003	–	–	0.03%	391
2013 Q2	$919K	Buy	+40,003	New	+$1.01M	0.02%	353

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

ICP

Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Visium Asset Management's CBPO Position: Q2 2016 in Review

Visium Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2016, closing a stake of 484,619 shares — an estimated $55.5M sold.

Visium Asset Management first reported a position in CBPO in Q2 2013 and held it in 12 quarters. The position peaked at $60.2M in Q4 2015. 138 funds tracked by Wall St. Rank hold CBPO as of Q2 2016.

Visium Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
Visium Asset Management sold 484,619 China Biologic Products Holdings, Inc. shares in Q2 2016, an estimated $55.5M.
Visium Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q2 2013 and held it in 12 quarters.
Visium Asset Management's China Biologic Products Holdings, Inc. position peaked at $60.2M in Q4 2015.
138 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.